Structure/function studies on IgE as a basis for the development of rational IgE antagonists

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue SUPPL. 45, 1998, Pages 77-82

  Helm, B A ^a   Sayers, L ^a   Padlan, E A ^b   McKendrick, J E ^a   Spivey, A C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN HEAVY CHAIN; OXYGEN RADICAL;

ALLERGENICITY; ANTIGEN ANTIBODY REACTION; ASTHMA; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HUMAN; IMMUNE RESPONSE; INDUSTRY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-ALLERGIC AGENTS; BINDING SITES, ANTIBODY; HUMANS; IMMUNOGLOBULIN E; RECEPTORS, IGE;

EID: 0031696729     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb04945.x     Document Type: Conference Paper

References (54)

1. Ishizaka K, Ishizaka T, Hornbrook MM. Physicochemical properties of human reaginic antibody. J Immunol 1966;97:840-5.
2. Bennich H, Ishizaka K, Johansson SG0, et al. A new class of human imrnunoglobulins. Bull World Health Organ 1968;38:151-4.
3. Capron A, Dessaint JP, Capron M, et al. From parasites to allergy: a second receptor for IgE. Immunol Today 1986;7:15-17.
4. Hagan F, Blumenthal V, Dunn G. Human IgE, IgG4 and resistance to re-infection with Schistosoma haematobium. Nature 1991;349:243-5.
5. Gounni AS, Lamkhioued B, Ochiai K, et al. High-Affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367:183-6.
6. Cookson WOCM, Moffat M. Asthma: an epidemic in the absence of infection. Science 1997;275:41-2.
7. Holgate ST. Holgate TA. The cellular and mediator basis of asthma in relation to natural history. Lancet 1997;350 Suppl 2:5-9.
8. Takenada H, Zhang K, Diaz-Sanchez D, et al. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B cell IgE production. J Allergy Clin Immunol 1995;95:103-15.
9. Brostoff J, Gamlin L. A modern disease. In: Hay fever. The complete guide. London: Bloomsbury, 1993:49-64.
10. Shirakawa T, Enomoto T, Shimazu 5, et al. The inverse relationship between tuberculin responses and atopic disorder. Science 1997;275:77-9.
11. Zeiss CR. Industrial asthma. In: Miyamato T, Okuda M, editors. Progress in allergy and clinical immunology. Vol. II. Seattle: Hogrefe & Huber, 1992:170-7.
12. Stanworth DR, Humphrey JH, Bennich HH, et al. Inhibition of Prausnitz-Kflstner reaction by proteolytic cleavage fragments of a human myeloma protein of immunoglobulin class E. Lancet 1968;2:17-18.
13. Ishizaka K, Ishizaka T, Lee EH. Biologic function of the Fc fragments of E myeloma protein. Immunochemistry 1970;7:687-95.
14. Lindstrom-Bahr H. Human immunoglohulin F: structural studies on the epsilon chain ND. PhD thesis, 1970, University of Uppsala.
15. Helm BA, Spivey AC, Padlan EA. Peptide blocking of IgE/ receptor interaction: possibilities and pitfalls. Allergy 1997;52:1155-69.
16. Vogel M, Miescher S, Biaggi C, et al. Human anti-IgE antibodies by repertoire cloning. Fur J Immunol 1994; 24:1200-7.
17. de Weck AL, Stadler B. Good or bad IgE and anti-IgE antibodies: new molecular concepts. In: Kraft D, Sehon A, editors. Molecular biology and immunology of allergens. Boca Raton, FL: CRC Press, 1993:101-12.
18. Shibazaki M, Sumazaki R, Isoyama 5, et al. Interaction of lectins with human IgE: IgE binding property and histamine releasing activity of twelve plant lectins. mt Arch Allergy Immunol 1992;98:18-25.
19. Machado DC, Horton D, Harrop R, et al. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of antigen-specific IgE. Eur J Immunol 1996;26:2972-80.
20. Jarrett E, Mackenzie S, Bennich HH. Parasite-induced nonspecific IgE does not protect against allergic reactions. Nature 1981;283:302-4.
21. McDonnell JM, Beavil AJ, Mackay GA, et al. Structure based design of peptides that inhibit IgE binding to its high affinity receptor. Biochem Soc Trans 1997;25:387-92.
22. Zutshi R, Brickner M, Chmielewski J. Inhibiting the assembly of protein-protein interfaces. Curr Opin Chem Biol 1998;2:62-6.
23. McDowell RS, Gadek TR, Barker PL, et al. From peptide to non-peptide. I. The elucidation of a bioactive conformation of the argenine-glycine-Aspartic acid recognition sequence. J Am Chem Soc 1994;116:5069-76.
24. McDowell RS, Blackburn BK, Gadek TR, et at. From peptide to non-peptide. II. The de novo design of potent, nonpeptidal inhibitors of platelet aggregation based on benzodiazepindione scaffold. J Am Chem Soc 1994;116:5077-83.
25. Merrifield RB. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 1963;85:2149.
26. Jung G, editor. Combinatorial peptide and nonpeptide libraries. New York: VCH, 1996.
27. Hruby VJ, Ahn J-M, Liao S. Synthesis of oligopeptide and peptidomimetic libraries. Curr Opin Chem Biol 1997;1:114-19.
28. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 1991;354:84-6.
29. Houghten RA, Appel JR, Blondelle SE, Cuervo JH, Dooley CT, Pinilla C. The use of synthetic peptide combinatorial libraries for the identification of bioactive pep- tides. Biotechniques 1992;13:412-21.
30. Furka A, Sebestyen F, Asgedom M, Dibo G. General method for rapid synthesis of multicomponent peptide mixtures. mt J Pept Protein Res 1991;37:487-93.
31. Sebestyen F, Dibo G, Kovacas A, Furka A. Chemical synthesis of peptide libraries. Bioorg Med Chem Lett 1993;3:413-18.
32. Lam KS, Salmon SE, Hersh EM, Huby VJ, Kazmiersky WM, Knapp SE. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 1991;354:82-4.
33. Kieber-Emmons T, Murali R, Green MI. Therapeutic peptides and peptidomimetics. Curr Opin Biotechnol 1997;8:435-41.
34. Salmon SE, Lam KS, Lebel M, et al. Discovery of biologically active peptides in random libraries: solution-phase testing after staged orthogonal release from resin beads. Proc Nati Acad Sci U S A 1993;90:11708-12.
35. Dooley CT, Houghten RA. The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. Life Sci 1993; 52:1509-17.
36. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315.
37. Livnah 0, Stura EA, Johnson DL, et al. Functional mimicry of a protein hormone by a peptide agonist - the EPO receptor complex at 2.8-Angstrom. Science 1996;273:464.
38. Yanofsky SD, Baldwin DN, Butler JH, et al. High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci U S A 1996;93:7381.
39. Wiegand T, Williams PB, Dreskin SC, et al. High-Affinity oligonucleotide ligands to human IgE inhibit binding to FcERI. J Immunol 1996;157:221-30.
40. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 A- and 2.8 A-resolution. Biochemistry 1981;299: 2361-70.
41. Padlan E, Davies DR. A model of the Pc of immunoglobulin E. Mol Immunol 1986;23:1063-8.
42. Pumphrey R. Modeling immunoglobulin domains. Immunol Today 1986;7:206-9.
43. Helm BA, Ling Y, Teale C, et al. The nature and importance of the inter-c chain disulphide bonds in human IgE. Eur J Immunol 1991;21:1543-8.
44. Beavil AJ, Beavil R, Chan C, et al. Structural basis of the IgE FcRI interaction. Biochem Soc Trans 1993; 21:968-72.
45. Sutton BJ, Gould HJ. The human IgE network. Nature 1993;366:421-8.
46. Presta L, Shields R, O'Connel L, et al. The binding site on human immunoglobulin E for its high affinity receptor. J Biol Chem 1994;269:26368-73.
47. Duncan AR, Woof JM, Partridge L, et al. Localisation of the binding site for the human high-Affinity receptor on IgG. Nature 1988;332:563-4.
48. Henry A, Cook JPD, McDonnel JM, et al. Participation of the N-terminal region of CE3 in the binding of human IgE to its high-Affinity receptor FceRI. Biochemistry 1997; 36:15568-78.
49. Helm BA, Sayers I, Higginbottom A. Identification of the high-Affinity receptor binding region in human IgE. J Biol Chem 1996:271:7494-7500.
50. Zheng Y, Shopes R, Holowka D, et al. Dynamic conformations compared for IgGi and IgE in solution and bound to the receptors. Biochemistry 1991;30:9125-36.
51. Sayers I. Protein engineering of recombinant human immunoglobulin E: mapping the Fc receptor binding regions. PhD, thesis, 1997, University of Sheffield.
52. Ben-Yedidia T, Arnon R. Design of peptide and polypeptide vaccines. Cuff Opin Biotechnol 1997;8:442-8.
53. Keown MB, Ghirlando GA, Mackay, et al. Basis of the 1:1 stoichiometry of the high affinity receptor FcRI-IgE complex. Eur Biophys J 1997;25:471-6.
54. Burmester WP, Huber AH, BjOrkman PJ. Crystal structure of the complex between the rat neonatal Pc receptor and Fc. Nature 1994;372:379-83.